https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accounts-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accounts-payable-other-current-and-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accounts-receivable-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrual-carrying-value-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-bonuses-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-employee-benefits-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-income-taxes-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-liabilities-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-rent-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-salaries-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-sales-commission-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accrued-vacation-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accumulated-depreciation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/acquired-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/acquired-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/acquired-noncurrent-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/acquired-noncurrent-liabilities-long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/additional-paid-in-capital https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/adjustment-for-amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amended-reports-10-k https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amended-reports-10-q https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amortization-of-deferred-charges https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/amortization-of-financing-costs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/asset-impairment-charges https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/assets-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/basic-shares https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/buybacks-share-repurchases https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capital-expenditures https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capital-lease-obligations-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capitalized-contract-cost-amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capitalized-contract-cost-impairment-loss https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/capitalized-contract-cost-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-acquired-from-acquisition https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-and-equivalents https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-and-restricted-cash https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-change https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-flow-breakdown https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/clinical-trials https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/common-stock-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/construction-in-progress-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/contract-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/convertible-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/convertible-debt-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cost-maintenance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cost-of-goods-sold https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cost-of-revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cover-page-shares-outstanding https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/current-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/current-income-tax-expense-benefit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/current-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/current-portion-of-long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/damages-sought-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-convertible-if-converted-value-in-excess-of-principal https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-convertible-number-of-equity-instruments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-decrease-forgiveness https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-face-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-interest-rate-at-period-end https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-after-year-five https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-next-rolling-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-rolling-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-year-four https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-year-three https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-in-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-periodic-payment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/debt-unamortized-discount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-finance-costs-current-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-finance-costs-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-income-tax-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-revenue-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-revenue-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-revenue-recognized https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-state-taxes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-warranty-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-other-finite-lived-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/deposits-assets-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/depreciation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/depreciation-amortization-and-accretion-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/depreciation-and-amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/depreciation-and-amortization-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/derivative-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/derivative-liabilities-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/diluted-shares https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-amount-of-adjustment-to-prior-period-gain-loss-on-disposal-net-of-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-amount-of-other-income-loss-from-disposition-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-gain-loss-from-disposal-of-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/discontinued-operation-tax-effect-of-income-loss-from-disposal-of-discontinued-operation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-accounts-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-accrued-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-cash-and-cash-equivalents https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-deferred-revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-deferred-tax-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-general-and-administrative-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-gross-profit-loss https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-intangible-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-interest-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-interest-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-inventory https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-other-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-other-current-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-other-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-other-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-property-plant-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/effective-tax-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/embedded-derivative-gain-on-embedded-derivative https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/entity-listing-par-value-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/eps https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/eps-basic https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-disclosure-offbalance-sheet-risks-amount-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-gain-loss-included-in-earnings https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-change https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-sales https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-settlements https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-interest-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-payments-due https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-principal-payments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/financing-cash-flow https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/form-d-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/form-d-stocks https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/goodwill-acquired https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/goodwill-impairment-loss https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/gross-profit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/impairment-of-leasehold https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/impairment-of-ongoing-project https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-per-basic-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-tax-expense-benefit-intraperiod-tax-allocation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-taxes-paid https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/income-taxes-paid-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-fair-value-of-price-risk-fair-value-hedging-instruments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-inventories https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-preferred https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-stock-options https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-stock-units https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-warrants https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/interest-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/interest-paid https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/interest-paid-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-finished-goods https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-lifo-reserve-period-charge https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-raw-materials https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-recall-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-supplies-net-of-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-valuation-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/inventory-write-down https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/investing-cash-flow https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/investment-income-interest https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/land https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lease-and-rental-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lessee-finance-lease-discount-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/level-3-liability-purchases-sales-issuances-settlements https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/liabilities-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/lines-of-credit-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/litigation-reserve-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/loans-payable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/loans-payable-to-bank https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/loans-payable-to-bank-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-three https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt-and-capital-lease-obligations-repayments-of-principal-in-next-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-debt-fair-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-loans-from-bank https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/long-term-loans-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/machinery-and-equipment-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-cash-from-financing-activities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-cash-from-investing-activities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-cash-from-operating-activities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-change-in-cash https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/net-rentable-area https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/notes-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/notes-payable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/notes-payable-related-parties-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/notes-reduction https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/number-of-operating-segments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/number-of-reportable-segments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/number-of-reporting-units https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-cash-flow https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-liability-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-receivable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-receivable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-receivable-in-four-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-receivable-in-three-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-receivable-in-two-years https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-rent-expense-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/operating-loss-carryforwards https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-accrued-liabilities-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-asset-impairment-charges https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-current-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-current-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-deferred-compensation-arrangements-liability-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-inventory-supplies https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-loans-payable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-loans-payable-long-term https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-noncurrent-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-noncurrent-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-nonoperating-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-nonoperating-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-nonoperating-income-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-prepaid-expense-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-receivables-net-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/patents-active https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/patents-pending https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/patents-rejected https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-for-fees https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-for-proceeds-from-other-deposits https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-for-rent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-for-restructuring https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-for-software https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-shares-facts https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-shares-authorized https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-shares-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/preferred-stock-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/prepaid-insurance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/prepaid-rent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/pretax-income https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-divestiture-of-interest-in-consolidated-subsidiaries https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-other-equity https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-payments-for-long-term-loans-for-related-parties https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-repayments-of-other-long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-sale-of-other-productive-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-sales-of-assets-investing-activities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-stock-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/profit-loss https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/property-plant-and-equipment-additions https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/property-plant-and-equipment-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/property-plant-and-equipment-transfers-and-changes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/property-plant-equipment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/provision-for-doubtful-accounts https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/provision-for-loan-lease-and-other-losses https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/public-float https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/purchase-obligations-purchases https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-bank-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-lines-of-credit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-notes-payable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-other-short-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-related-party-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/repayments-of-short-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/research-and-development https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restricted-cash-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restricted-stock-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restructuring-charges https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restructuring-reserve https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/retained-earnings https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/revenue https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sale-of-stock-price-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sales-revenue-goods-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sales-revenue-net https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-comment-letters-corresp https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-comment-letters-upload https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-10-k https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-10-kt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-10-q https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-10ksb https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-10qsb https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-25-nse https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-425 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-8-a12b https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-8-a12g https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-8-k https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-ars https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-certnas https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-ct-order https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-def-14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-defa14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-defc14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-defm14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-defr14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-dfan14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-pre-14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-prec14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-prem14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-prer14a https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-px14a6g https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-regdex https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-s-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-s-4 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sec-filings-sb-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-effect https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-fwp https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-rw https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/secured-debt-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/security-deposit https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/sga-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/share-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shareholders-equity https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-authorized https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-2 https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-for-acquisitions https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-for-options-exercised https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-for-stock-awards https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-price-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-new-issues https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-award-rsu-grants-in-period-intrinsic-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-based-compensation https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-new-shares-sold https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-option-plan-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-exercisable-number https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-grants-in-period https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-outstanding-number https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stock-split-ratio https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/stockholders-equity-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/taxes-payable-current https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/temporary-equity-shares-authorized https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/total-assets https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/total-contract-liability https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/total-liabilities https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/total-liabilities-and-equity https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/total-long-term-debt https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/treasury-stock-common-shares https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/treasury-stock-shares https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/treasury-stock-value https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/warrants-and-rights-outstanding https://stock.noler.com/us/stock/dmk-pharmaceuticals-corporation/weighted-average-number-of-share-outstanding-basic-and-diluted